For horses that respond to OSPHOS and keep their clinical improvement for 6 months, it is best to re-administer only when clinical indicators recur. This really early response might not be an indication from the lengthy-term effectiveness of the medication (it could be unbiased of the leading, bone modifying outcomes). https://horsemedicinestore.com/product/tildren-for-horses/